| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
1,648 |
1,446 |
$55K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
283 |
261 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
92 |
85 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
113 |
100 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33 |
29 |
$3K |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$1K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
69 |
37 |
$833.47 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
26 |
17 |
$494.18 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
83 |
75 |
$110.04 |
| 99051 |
|
158 |
140 |
$0.00 |
| 99000 |
|
54 |
46 |
$0.00 |